欧洲医用酶技术市场预测至 2028 年 - COVID-19 影响和酶类型(消化酶、溶栓酶、水解酶和核酸内切酶)的区域分析;应用(疾病治疗、诊断工具、生物医学研究等)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 173    |    Report Code: TIPRE00025045    |    Category: Life Sciences

Europe Medical Enzyme Technology Market

市场介绍

酶是植物、动物和微生物的活细胞中产生的蛋白质。所有生物体都需要酶来生长以及产生和利用生命所必需的能量。在活细胞中,酶充当催化剂,加速控制生命过程的化学反应。一百多年来,酶一直是重要的工业产品。然而,潜在的应用范围正在迅速扩大。随着重组 DNA 技术的出现,大量生产以前稀有的酶已成为可能,从而降低了成本。此外,在药品制造中,制造手性纯化合物的愿望正在带来新的机遇。技术进步促进了酶在越来越广泛的工艺条件下的使用。

因此,研究和开发活动的显着增加预计将在未来几年对医用酶技术产生巨大需求,预计这将进一步推动医用酶技术市场的发展。

欧洲地区国家因 COVID-19 大流行而受到严重影响。例如,意大利、西班牙和法国等国家报告的阳性病例数最多,死亡人数最多。欧洲国家在今年年初成功缓解疫情后,发现 COVID-19 病例再次出现。许多国家现在每天宣布的病例数量比今年早些时候第一波疫情期间还要多。根据欧洲疾病预防和控制中心 (ECDC) 的数据,英国、西班牙、意大利和爱尔兰正在重新实施封锁。与此同时,欧洲正试图从 COVID-19 危机对公民健康和经济稳定的影响中恢复过来。欧洲绿色协议中的新政策将试图减轻疫情的影响。生物技术可以成为这一复苏的宝贵工具,从帮助我们实现“从农场到餐桌”战略目标的现代植物育种方法,到帮助我们阻止大流行的制药和医疗创新。农业生物技术改善了动物营养,开发了动物疫苗,并改进了疯牛病、口蹄疫和沙门氏菌的诊断。它还使得酶的使用成为可能。因此,欧洲基因组市场在这次大流行期间和预测的年份可能会显示出显着的增长前景。

 

市场概况和动态

欧洲医用酶技术市场预计将从2021年的11.645亿美元增长到2028年的17.996亿美元;预计 2021 年至 2028 年复合年增长率为 6.4%。生物制药是制药和生物技术行业不断增长的业务领域之一。自 1982 年推出以来,生物制药彻底改变了多种疾病的治疗方法,并且越来越多地应用于几乎所有医学分支。尽管需要投入大量时间和资金,生物制药市场仍在快速增长。

 

关键细分市场

从酶类型来看,水解酶领域占据2020年欧洲医用酶技术市场最大份额。从应用来看,疾病治疗领域占据欧洲医用酶最大份额2020 年技术市场。

 

主要来源和上市公司

准备本欧洲医用酶技术市场报告时参考的一些主要一手和二手资料包括公司网站、年度报告、财务报告、国家政府文件和统计数据库,除其他外。报告中列出的主要公司包括 Merck Kgaa、Thermo Fisher Scientific Inc.、Novozymes、Takeda Pharmaceutical Company Limited、Agilent Technologies, Inc.、Genzyme Corporation、Asahi Kasei Corporation、Promega Corporation、Cytiva 和 Amano Enzyme Inc.

 

< span>购买报告的理由

  • 了解欧洲医用酶技术市场格局并确定最有可能的细分市场保证丰厚的回报
  • 了解欧洲医用酶技术市场不断变化的竞争格局,保持领先地位
  • 有效规划欧洲医用酶技术的并购和合作交易通过识别最有可能销售的细分市场来了解市场
  • 通过对欧洲医用酶技术市场各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策
  • 获取市场欧洲地区2021-2028年各细分市场的收入预测

 

< strong>欧洲医疗酶技术市场细分

按酶类型

  • 消化酶
    • L-天冬酰胺酶
    • 乳糖酶
    • 其他
    • 溶栓酶
      • 链激酶
      • 尿激酶
      • 其他
    • 水解酶
      • 透明质酸酶
      • 溶菌酶
      • 其他
    • 核酸内切酶
      • 苯佐酶
      • 其他
    < p> 

    按应用

    • 疾病治疗
    • 诊断工具
    • 生物医学研究
    • 其他

     < /p>

    按国家/地区

    • 欧洲
      • 德国
      • 英国
      • 法国
      • 西班牙
      • < span>意大利
      • 欧洲其他地区

     

    提及的公司

    1. Merck Kgaa
    2. Thermo Fisher Scientific Inc.
    3. Novozymes
    4. 武田药品工业株式会社
    5. 安捷伦科技公司
    6. Genzyme Corporation
    7. 旭化成株式会社
    8. Promega株式会社
    9. Cytiva
    10. 天野酶株式会社

     

     

     

    Europe Medical Enzyme Technology Strategic Insights

    Strategic insights for Europe Medical Enzyme Technology involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/europe-medical-enzyme-technology-market-strategic-framework.webp
    Get more information on this report

    Europe Medical Enzyme Technology Report Scope

    Report Attribute Details
    Market size in 2021 US$ 1,164.5 Million
    Market Size by 2028 US$ 1,799.6 Million
    Global CAGR (2021 - 2028) 6.4%
    Historical Data 2019-2020
    Forecast period 2022-2028
    Segments Covered By 酶类型
    • 消化酶
    • 血栓溶解酶
    • 水解酶
    • 核酸内切酶
    By 应用
    • 疾病治疗
    • 诊断工具
    • 生物医学研究
    Regions and Countries Covered 欧洲
    • 英国
    • 德国
    • 法国
    • 俄罗斯
    • 意大利
    • 欧洲其他地区
    Market leaders and key company profiles
  • Merck Kgaa
  • Thermo Fisher Scientific Inc.
  • Novozymes
  • Takeda Pharmaceutical Company Limited
  • Agilent Technologies, Inc.
  • Genzyme Corporation
  • Asahi Kasei Corporation
  • Promega Corporation
  • Cytiva
  • Amano Enzyme Inc.
  • Get more information on this report

    Europe Medical Enzyme Technology Regional Insights

    The regional scope of Europe Medical Enzyme Technology refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-medical-enzyme-technology-market-geography.webp
    Get more information on this report

The List of Companies - Europe Medical Enzyme Technology Market

  1. Merck Kgaa
  2. Thermo Fisher Scientific Inc.
  3. Novozymes
  4. Takeda Pharmaceutical Company Limited
  5. Agilent Technologies, Inc.
  6. Genzyme Corporation
  7. Asahi Kasei Corporation
  8. Promega Corporation
  9. Cytiva
  10. Amano Enzyme Inc.        

 

Frequently Asked Questions
How big is the Europe Medical Enzyme Technology Market?

The Europe Medical Enzyme Technology Market is valued at US$ 1,164.5 Million in 2021, it is projected to reach US$ 1,799.6 Million by 2028.

What is the CAGR for Europe Medical Enzyme Technology Market by (2021 - 2028)?

As per our report Europe Medical Enzyme Technology Market, the market size is valued at US$ 1,164.5 Million in 2021, projecting it to reach US$ 1,799.6 Million by 2028. This translates to a CAGR of approximately 6.4% during the forecast period.

What segments are covered in this report?

The Europe Medical Enzyme Technology Market report typically cover these key segments-

  • 酶类型 (消化酶, 血栓溶解酶, 水解酶, 核酸内切酶)
  • 应用 (疾病治疗, 诊断工具, 生物医学研究)
  • What is the historic period, base year, and forecast period taken for Europe Medical Enzyme Technology Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Medical Enzyme Technology Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Europe Medical Enzyme Technology Market?

    The Europe Medical Enzyme Technology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Merck Kgaa
  • Thermo Fisher Scientific Inc.
  • Novozymes
  • Takeda Pharmaceutical Company Limited
  • Agilent Technologies, Inc.
  • Genzyme Corporation
  • Asahi Kasei Corporation
  • Promega Corporation
  • Cytiva
  • Amano Enzyme Inc.
  • Who should buy this report?

    The Europe Medical Enzyme Technology Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Medical Enzyme Technology Market value chain can benefit from the information contained in a comprehensive market report.